These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29660203)

  • 1. Mycobacterium tuberculosis: Active disease and latent infection in a renal transplant cohort.
    Rafiei N; Williams J; Mulley WR; Trauer JM; Jenkin GA; Rogers BA
    Nephrology (Carlton); 2019 May; 24(5):569-574. PubMed ID: 29660203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.
    Blount RJ; Tran MC; Everett CK; Cattamanchi A; Metcalfe JZ; Connor D; Miller CR; Grinsdale J; Higashi J; Nahid P
    BMC Public Health; 2016 Aug; 16(1):875. PubMed ID: 27558397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positivity rate of interferon-γ release assays for estimating the prevalence of latent tuberculosis infection in renal transplant recipients in Japan.
    Igari H; Akutsu N; Ishikawa S; Aoyama H; Otsuki K; Hasegawa M; Maruyama M; Tsuyuzaki M; Suzuki K; Saigo K
    J Infect Chemother; 2019 Jul; 25(7):537-542. PubMed ID: 30905632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants.
    Campbell JR; Krot J; Elwood K; Cook V; Marra F
    Mol Diagn Ther; 2015 Feb; 19(1):9-24. PubMed ID: 25579159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic potential of interferon-gamma release assay to detect latent tuberculosis infection in kidney transplant recipients.
    Edathodu J; Varghese B; Alrajhi AA; Shoukri M; Nazmi A; Elgamal H; Aleid H; Alrabiah F; Ashraff A; Mahmoud I; Al-Hajoj S
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28170135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculin Skin Test and Quantiferon in BCG Vaccinated, Immunosuppressed Patients with Moderate-to-Severe Inflammatory Bowel Disease.
    Kurti Z; Lovasz BD; Gecse KB; Balint A; Farkas K; Morocza-Szabo A; Gyurcsanyi A; Kristof K; Vegh Z; Gonczi L; Kiss LS; Golovics PA; Lakatos L; Molnar T; Lakatos PL
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):467-72. PubMed ID: 26697573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, Outcomes, and Long-term Immune Response to Tuberculosis in Organ Transplant Recipients.
    Natori Y; Ferreira VH; Nellimarla S; Husain S; Rotstein C; Humar A; Kumar D
    Transplantation; 2019 Jan; 103(1):210-215. PubMed ID: 29944616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Tuberculosis Among Immigrants in Korea Who Participated in a Latent Tuberculosis Infection Screening Program.
    Lee YJ; Min J; Myong JP; Lee YH; Park YJ; Kim Y; Kim G; Park G; Lee SS; Park JS; Kim JS; Kim HW
    J Korean Med Sci; 2024 Jul; 39(28):e207. PubMed ID: 39048302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does chronic immunosuppressive therapy for autoimmune disease influence the risk of developing active tuberculosis?
    Bardazzi F; Leuzzi M; Ferrara F; Patrizi A; Loi C
    Dermatol Ther; 2019 Jan; 32(1):e12777. PubMed ID: 30371983
    [No Abstract]   [Full Text] [Related]  

  • 12. Poor predictability of QuantiFERON-TB assay in recipients and donors for tuberculosis development after kidney transplantation in an intermediate-TB-burden country.
    Jambaldorj E; Han M; Jeong JC; Koo TY; Min SI; Song EY; Ha J; Ahn C; Yang J
    BMC Nephrol; 2017 Mar; 18(1):88. PubMed ID: 28292277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis and biologics in rheumatology: A special situation.
    Handa R; Upadhyaya S; Kapoor S; Jois R; Pandey BD; Bhatnagar AK; Khanna A; Goyal V; Kumar K
    Int J Rheum Dis; 2017 Oct; 20(10):1313-1325. PubMed ID: 28730751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing tuberculosis in the foreign-born population of Canada: a mathematical modelling study.
    Varughese MB; Langlois-Klassen D; Long R; Li M
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):405-12. PubMed ID: 24670694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti-TNF therapy: an Italian nationwide survey.
    Cantini F; Lubrano E; Marchesoni A; Mathieu A; Olivieri I; Salvarani C; Scarpa R; Spadaro A
    Int J Rheum Dis; 2016 Aug; 19(8):799-805. PubMed ID: 26172207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial testing for latent tuberculosis infection in transplant candidates: a retrospective review.
    Roth PJ; Grim SA; Gallitano S; Adams W; Clark NM; Layden JE
    Transpl Infect Dis; 2016 Feb; 18(1):14-21. PubMed ID: 26671024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.
    Sester M; van Leth F; Bruchfeld J; Bumbacea D; Cirillo DM; Dilektasli AG; Domínguez J; Duarte R; Ernst M; Eyuboglu FO; Gerogianni I; Girardi E; Goletti D; Janssens JP; Julander I; Lange B; Latorre I; Losi M; Markova R; Matteelli A; Milburn H; Ravn P; Scholman T; Soccal PM; Straub M; Wagner D; Wolf T; Yalcin A; Lange C;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1168-76. PubMed ID: 25303140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent tuberculosis infection--Revisiting and revising concepts.
    Salgame P; Geadas C; Collins L; Jones-López E; Ellner JJ
    Tuberculosis (Edinb); 2015 Jul; 95(4):373-84. PubMed ID: 26038289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of interferon-gamma release assay (T-SPOT.TB(™) ) for diagnosis of tuberculosis infection in rheumatic disease patients.
    Jiang B; Ding H; Zhou L; Chen X; Chen S; Bao C
    Int J Rheum Dis; 2016 Jan; 19(1):38-42. PubMed ID: 26820838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Close contact interferon-gamma response to the new PstS1
    de Araujo LS; de Bárbara Moreira da Silva Lins N; Leung JA; Mello FC; Saad MH
    BMC Res Notes; 2017 Jan; 10(1):59. PubMed ID: 28114976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.